Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17

Nature Communications

Volumn 2, Issue 1, 2011, Pages

  Maretzky, Thorsten ^a   Evers, Astrid ^b   Zhou, Wenhui ^a   Swendeman, Steven L ^a   Wong, Pui Mun ^c   Rafii, Shahin ^c   Reiss, Karina ^b   Blobel, Carl P ^a,c  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; VASCULOTROPIN RECEPTOR 2; ADAM PROTEIN; EPIDERMAL GROWTH FACTOR; FGF7 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; MAPK1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TRANSACTIVATION; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; CELL LINE; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; FEMALE; FETUS; FETUS BLOOD; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE;

ADAM PROTEINS; ANIMALS; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; EPIDERMAL GROWTH FACTOR; FEMALE; FETAL BLOOD; FETUS; FIBROBLAST GROWTH FACTOR 7; GENE EXPRESSION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KERATINOCYTES; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 79952480540     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1232     Document Type: Article

References (57)

1. Gamady, A., Koren, R., Ron, D., Liberman, U. A. & Ravid, A. Vitamin D enhances mitogenesis mediated by keratinocyte growth factor receptor in keratinocytes. J. Cell Biochem. 89, 440-449 (2003). (Pubitemid 36648766)
2. Finch, P. W. & Rubin, J. S. Keratinocyte growth factor/fbroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv. CancerRes. 91, 69-136 (2004). (Pubitemid 39140957)
3. Uzan, B., Figeac, F., Portha, B. & Movassat, J. Mechanisms of KGF mediated signaling in pancreatic duct cell proliferation and diferentiation. PLoS One 4, e4734 (2009).
4. Swendeman, S. et al VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling. Circ Res. 103, 916-918 (2008).
5. Gschwind, A., Hart, S., Fischer, O. M. & Ullrich, A. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J. 22, 2411-2421 (2003). (Pubitemid 36604980)
6. Fischer, O. M., Hart, S., Gschwind, A. & Ullrich, A. EGFR signal transactivation in cancer cells. Biochem. Soc Trans. 31, 1203-1208 (2003). (Pubitemid 38030939)
7. Schafer, B., Gschwind, A. & Ullrich, A. Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene 23, 991-999 (2004). (Pubitemid 38250945)
8. Luetteke, N. C. et al Te mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev. 8, 399-413 (1994). (Pubitemid 24071181)
9. Sibilia, M. & Wagner, E. F. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269, 234-238 (1995).
10. Peschon, J. J. et al An essential role for ectodomain shedding in mammalian development. Science 282, 1281-1284 (1998). (Pubitemid 28524483)
11. Luetteke, N. C. et al TGF alpha defciency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73, 263-278 (1993). (Pubitemid 23123306)
12. Mine, N., Iwamoto, R. & Mekada, E. HB-EGF promotes epithelial cell migration in eyelid development. Development 132, 4317-4326 (2005). (Pubitemid 41576693)
13. Jackson, L. F. et al Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J. 22, 2704-2716 (2003). (Pubitemid 36712367)
14. Sahin, U. et al Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR-ligands. J. Cell. Biol. 164, 769-779 (2004). (Pubitemid 38282960)
15. Iwamoto, R. et al Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc NatlAcad. Sci. USA 100, 3221-3226 (2003). (Pubitemid 36356564)
16. Yamazaki, S. et al Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J. Cell. Biol. 163, 469-475 (2003). (Pubitemid 37429861)
17. Chen, B. et al Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat. Genet. 24, 296-299 (2000). (Pubitemid 30132202)
18. Sternlicht, M. D. et al Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development 132, 3923-3933 (2005). (Pubitemid 41410256)
19. Dlugosz, A. A. et al Keratinocyte growth factor receptor ligands induce transforming growth factor alpha expression and activate the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes. Cell Growth Difer. 5, 1283-1292 (1994). (Pubitemid 24381516)
20. Koivisto, L., Jiang, G., Hakkinen, L., Chan, B. & Larjava, H. HaCaT keratinocyte migration is dependent on epidermal growth factor receptor signaling and glycogen synthase kinase-3alpha. Exp. CellRes. 312, 2791-2805 (2006).
21. De Giorgi, V., Sestini, S., Massi, D., Ghersetich, I. & Lotti, T. Keratinocyte growth factor receptors. Dermatol. Clin. 25, 477-485, vii (2007). (Pubitemid 47446086)
22. Prenzel, N. et al EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402 (1999).
23. Arora, P, Cuevas, B. D., Russo, A., Johnson, G. L. & Trejo, J. Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion. Oncogene 27, 4434-4445 (2008).
24. Ullrich, A. et al Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplifed gene in A431 epidermoid carcinoma cells. Nature 309, 418-425 (1984). (Pubitemid 14102443)
25. Mitamura, T., Higashiyama, S., Taniguchi, N., Klagsbrun, M. & Mekada, E. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifcally its mitogenic activity. J. Biol. Chem. 270, 1015-1019 (1995).
26. Blobel, C P. ADAMs: key players in EGFR-signaling, development and disease. Nat Rev. Mol. Cell Bio. 6, 32-43 (2005).
27. Horiuchi, K. et al Substrate selectivity of EGF-receptor ligand sheddases and their regulation by phorbol esters and calcium infux. Mol. Biol. Cell. 18, 176-188 (2007). (Pubitemid 46066719)
28. Sunnarborg, S. W. et al Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability J. Biol. Chem. 277, 12838-12845 (2002). (Pubitemid 34952648)
29. Xu, P. & Derynck, R. Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. Mol. Cell 37, 551-566 (2010).
30. Le Gall, S. M. et al ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site. J. Cell. Sci. 123, 3913-3922 (2010).
31. Schneider, M. R., Werner, S., Paus, R. & Wolf, E. Beyond wavy hairs: the epidermal growth factor receptor and its ligands in skin biology and pathology Am. J. Pathol. 173, 14-24 (2008). (Pubitemid 351947951)
32. Weskamp, G. et al. Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes. Circ Res. 106, 932-940 (2010).
33. Canault, M., Certel, K., Schatzberg, D., Wagner, D. D. & Hynes, R. O. Te lack of ADAM17 activity during embryonic development causes hemorrhage and impairs vessel formation. PLoS One 5, e13433 (2010).
34. Gao, L., Chao, L. & Chao, J. A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: activation of proteinase-activated receptor 1 and epidermal growth factor receptor. Exp. Cell Res. 316, 376-389 (2010).
35. Yahata, Y. et al A novel function of angiotensin II in skin wound healing. Induction of fbroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation. J. Biol. Chem. 281, 13209-13216 (2006). (Pubitemid 43855232)
36. Tokumaru, S. et al Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J. Immunol. 175, 4662-4668 (2005). (Pubitemid 41362007)
37. Ohtsu, H. et al ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II. Arterioscler. Tromb. Vasc Biol. 26, e133-e137 (2006). (Pubitemid 44253770)
38. Horiuchi, K. et al Cutting edge: TNF-{alpha}-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J. Immunol 179, 2686-2689 (2007).
39. Soond, S. M., Everson, B., Riches, D. W. & Murphy, G. ERK-mediated phosphorylation of Tr735 in TNFalpha-converting enzyme and its potential role in TACE protein trafcking. J. Cell. Sci. 118, 2371-2380 (2005). (Pubitemid 40873077)
40. Diaz-Rodriguez, E., Montero, J. C., Esparis-Ogando, A., Yuste, L. & Pandiella, A. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. Mol. Biol. Cell 13, 2031-2044 (2002). (Pubitemid 34651490)
41. Maretzky, T., Zhou, W., Huang, X.-Y & Blobel, C. P. A transforming Src mutant increases the bioavailability of EGFR-ligands via sitmulation of the cell surface metalloproteinase ADAM17. Oncogene 30, 611-618 (2011).
42. Ceccarelli, S. et al Cortactin involvement in the keratinocyte growth factor and fbroblast growth factor 10 promotion of migration and cortical actin assembly in human keratinocytes. Exp. Cell. Res. 313, 1758-1777 (2007). (Pubitemid 46653878)
43. Boukamp, P. & Fusenig, N. E. 'Trans-Diferentiation' from epidermal to mesenchymal/myogenic phenotype is associated with a drastic change in cell-cell and cell-matrix adhesion molecules. J. Cell. Biol. 120, 981-993 (1993). (Pubitemid 23056303)
44. Hartmann, D. et al Te disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fbroblasts. Hum. Mol. Genet 11, 2615-2624 (2002). (Pubitemid 35174691)
45. Ma, Y C., Huang, J., Ali, S., Lowry, W. & Huang, X. Y Src tyrosine kinase is a novel direct efector of G proteins. Cell 102, 635-646 (2000).
46. Maretzky, T. et al. Characterization of the catalytic activity of the membrane-anchored metalloproteinase ADAM15 in cell-based assays. Biochem. J. 420, 105-113 (2009).
47. Schlöndorf, J., Becherer, J. D. & Blobel, C. P. Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). Biochem. J. 347 (Part 1), 131-138 (2000). (Pubitemid 30199050)
48. Weskamp, G. et al. ADAM10 is a principal 'sheddase' of the low-afnity immunoglobulin E receptor CD23. Nat. Immunol. 7, 1393-1298 (2006).
49. Le Gall, S. et al ADAMs 10 and 17 represent diferentially regulated components of a general shedding machinery for membrane proteins such as TGFα, L-Selectin and TNFα. Mol. Biol. Cell 20, 1785-1794 (2009).
50. Peduto, L., Reuter, V. E., Shafer, D. R., Scher, H. I. & Blobel, C. P. Critical function for ADAM9 in mouse prostate cancer. Cancer Res. 65, 9312-9319 (2005). (Pubitemid 41507998)
51. Maretzky, T. et al. Src stimulates fbroblast growth factor receptor-2 shedding by an ADAM15 splice variant linked to breast cancer. Cancer Res. 69, 4573-4576 (2009).
52. Zheng, Y, Schlondorf, J. & Blobel, C. P. Evidence for regulation of the tumor necrosis factor alpha-convertase (TACE) by protein-tyrosine phosphatase PTPH1. J. Biol. Chem. 277, 42463-42470 (2002). (Pubitemid 35285612)
53. Zheng, Y, Safig, P., Hartmann, D. & Blobel, C. Evaluation of the contribution of diferent ADAMs to TNFα shedding and of the function of the TNFα ectodomain in ensuring selective stimulated shedding by the TNFα convertase (TACE/ADAM17). J. Biol. Chem. 279, 42898-42906 (2004). (Pubitemid 39372180)
54. Sahin, U. et al in Epidermal Growth Factor: Methods and Protocols Vol. 327 Methods inMolecular Biology (eds Patel, T. B. & Bertics, P. J.) 99-113 (Humana Press, 2006).
55. Maretzky, T. et al. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad. Sci. USA 102, 9182-9187 (2005). (Pubitemid 40923538)
56. Cooper, J. A., Scolnick, E. M., Ozanne, B. & Hunter, T. Epidermal growth factor receptor metabolism and protein kinase activity in human A431 cells infected with Snyder-Teilen feline sarcoma virus or harvey or Kirsten murine sarcoma virus. J. Virol. 48, 752-764 (1983). (Pubitemid 14232287)
57. Pastore, S., Mascia, F., Mariani, V. & Girolomoni, G. Te epidermal growth factor receptor system in skin repair and infammation. J. Invest Dermatol 128, 1365-1374 (2008). (Pubitemid 351693180)